<code id='998930037F'></code><style id='998930037F'></style>
    • <acronym id='998930037F'></acronym>
      <center id='998930037F'><center id='998930037F'><tfoot id='998930037F'></tfoot></center><abbr id='998930037F'><dir id='998930037F'><tfoot id='998930037F'></tfoot><noframes id='998930037F'>

    • <optgroup id='998930037F'><strike id='998930037F'><sup id='998930037F'></sup></strike><code id='998930037F'></code></optgroup>
        1. <b id='998930037F'><label id='998930037F'><select id='998930037F'><dt id='998930037F'><span id='998930037F'></span></dt></select></label></b><u id='998930037F'></u>
          <i id='998930037F'><strike id='998930037F'><tt id='998930037F'><pre id='998930037F'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:96111
          Doctor sitting at a crowded desk. -- first opinion coverage from STAT
          Adobe

          SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

          Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

          advertisement

          “It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Readout Newsletter: Ironwood, Pfizer, FogPharma updates
          Readout Newsletter: Ironwood, Pfizer, FogPharma updates

          DavidLRyan/TheBostonGlobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourb

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Biotech companies concerned about China biosecurity crackdown

          AdobeWASHINGTON—ThefederalgovernmentincreasinglyisscrutinizingChinesebusinessesandtheirinteractionsw